mTOR inhibitors are efficacious treatments for some of the tumours associated with TSC including sirolimus for pulmonary lymphangioleiomyomatosis (LAM) and renal angiomyolipoma (AML),87 everolimus for SEGA not amenable to surgery,88 and everolimus for AML.89 Here, MTOR is linked to acute myeloid leukemia.